Vivitrol Treatment Consent And Agreement

The pill form can be taken daily for AUD, but the injectable formulation with extended release is allowed for the treatment of OUD. The form of the pill is taken daily and the injectable injection with extended release is administered by a practitioner every four weeks or once a month. Naltrexone binds to endorphin receptors in the body and blocks the effects and feelings of alcohol. Naltrexone reduces the desire for alcohol and the amount of alcohol consumed. As soon as a patient stops drinking, taking naltrexone helps patients maintain their sobriety. Treatment with Naltrexone-MAT lasts from three to four months. Physicians should continue to monitor patients who are no longer taking naltrexone. Contact SAMHSA`s OTP Regional Compliance Officers to determine if an OTP is qualified to treat substance use disorders. Naltrexone is a component of a comprehensive treatment plan that includes counseling and other behavioral health treatments to provide patients with a holistic approach. Naltrexone is not a recommended AD option for people under 18 years of age or for patients with other health conditions.

For information on other drug treatments (MAT) or certification of opioid treatment programs (OTPs), please contact the SAMHSA Division of Pharmacological Therapies at 240-276-2700. . . .

Comments are closed.